athenahealth, Inc. (NASDAQ:ATHN) reported Q2 2017 earnings this Afternoon, coming in at $0.51 per share, beating Wall Street’s estimates of $0.39 per Share. Revenue for the quarter came in at $301.10 million beating analyst estimates of $298.68 million
Analyst Coverage For athenahealth, Inc. (NASDAQ:ATHN)
These are 1 Sell Rating, 11 Hold Ratings, 11 Buy Ratings .
The current consensus rating for athenahealth, Inc. (NASDAQ:ATHN) is Hold (Score: 2.43) with a consensus target price of $140.45 , a potential (2.33% downside)Recent Insider Trading for athenahealth, Inc. (NASDAQ:ATHN)
- On 7/17/2017 Jonathan D. Porter, SVP, sold 300 with an average share price of $143.13 per share and the total transaction amounting to $42,939.00.
- On 7/3/2017 Brandon H. Hull, Director, sold 800 with an average share price of $140.81 per share and the total transaction amounting to $112,648.00.
- On 7/3/2017 Jonathan Bush, CEO, sold 4,000 with an average share price of $140.52 per share and the total transaction amounting to $562,080.00.
- On 6/15/2017 Jonathan D. Porter, SVP, sold 300 with an average share price of $142.27 per share and the total transaction amounting to $42,681.00.
- On 6/5/2017 Karl Stubelis, CFO, sold 3,952 with an average share price of $138.98 per share and the total transaction amounting to $549,248.96.
- On 5/18/2017 Bradford Kyle Armbrester, SVP, sold 2,431 with an average share price of $130.00 per share and the total transaction amounting to $316,030.00.
Recent Trading for athenahealth, Inc. (NASDAQ:ATHN) Shares of athenahealth, Inc. closed the previous trading session at 143.80 up +0.42 0.29% with 680,157 shares trading hands.